Connection
Nishank Jain to Cardiovascular Diseases
This is a "connection" page, showing publications Nishank Jain has written about Cardiovascular Diseases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.879 |
|
|
|
-
Jain N, McAdams M, Hedayati SS. Screening for Cardiovascular Disease in CKD: PRO. Kidney360. 2022 11 24; 3(11):1831-1835.
Score: 0.553
-
Jain N, Hunt SL, Cui H, Phadnis MA, Mahnken JD, Shireman TI, Dai J, Mehta JL, Rasu RS. Trends for and Clinical Factors Associated with Choice of Oral P2Y12 Inhibitors for Patients on Chronic Dialysis. Cardiovasc Drugs Ther. 2019 10; 33(5):511-521.
Score: 0.468
-
Jain N, Elsayed EF. Dietary phosphate: what do we know about its toxicity. J Nephrol. 2013 Sep-Oct; 26(5):856-64.
Score: 0.294
-
Jain N, Hedayati SS, Sarode R, Banerjee S, Reilly RF. Antiplatelet therapy in the management of cardiovascular disease in patients with CKD: what is the evidence? Clin J Am Soc Nephrol. 2013 Apr; 8(4):665-74.
Score: 0.288
-
Jain N, Kotla S, Little BB, Weideman RA, Brilakis ES, Reilly RF, Banerjee S. Predictors of hyperkalemia and death in patients with cardiac and renal disease. Am J Cardiol. 2012 May 15; 109(10):1510-3.
Score: 0.276